12:00 AM
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Deals

Pieris, Sanofi deal

The companies will expand a 2010 deal under which Pieris is using its Anticalin technology to discover and develop Anticalin candidates against undisclosed targets selected by Sanofi to include an additional multi-specific Anticalin program. For the new program, Pieris will receive an...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >